z-logo
open-access-imgOpen Access
Novel perspective: exercise training stimulus triggers the expression of the oncoprotein human double minute‐2 in human skeletal muscle
Author(s) -
Roudier Emilie,
Aiken Julian,
Slopack Dara,
Gouzi Fares,
Mercier Jacques,
Haas Tara L.,
Gustafsson Thomas,
Hayot Maurice,
Birot Olivier
Publication year - 2013
Publication title -
physiological reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 39
ISSN - 2051-817X
DOI - 10.1002/phy2.28
Subject(s) - skeletal muscle , foxo1 , biology , transcription factor , context (archaeology) , angiogenesis , cancer research , medicine , endocrinology , gene , biochemistry , paleontology
High expression levels of human double minute‐2 (Hdm2) are often associated with increased risk of cancer. Hdm2 is well established as an oncoprotein exerting various tumorigenic effects. Conversely, the physiological functions of Hdm2 in nontumor cells and healthy tissues remain largely unknown. We previously demonstrated that exercise training stimulates expression of murine double minute‐2 (Mdm2), the murine analog of Hdm2, in rodent skeletal muscle and Mdm2 was required for exercise‐induced muscle angiogenesis. Here we showed that exercise training stimulated the expression of Hdm2 protein in human skeletal muscle from +38% to +81%. This robust physiological response was observed in 60–70% of the subjects tested, in both young and senior populations. Similarly, exercise training stimulated the expression of platelet endothelial cell adhesion molecule‐1, an indicator of the level of muscle capillarization. Interestingly, a concomitant decrease in the tumor suppressor forkhead box O‐1 (FoxO1) transcription factor levels did not occur with training although Mdm2/Hdm2 is known to inhibit FoxO1 expression in diseased skeletal muscle. This could suggest that Hdm2 has different targets when stimulated in a physiological context and that exercise training could be considered therapeutically in the context of cancer in combination with anti‐Hdm2 drug therapies in order to preserve Hdm2 physiological functions in healthy tissues.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here